(Total Views: 233)
Posted On: 07/22/2019 9:20:48 AM
Post# of 15407

$CYTR News Article - CytRx Corporation Highlights Arimoclomol Licensee Orphazyme A/S Completes Enrollment in its Phase 3 Clinical Trial of Arimoclomol in Amyotrophic Lateral Sclerosis https://marketwirenews.com/news-releases/cytr...82608.html


My Twitter: WhyteStocks